drugset / Trial / NCT02319941

Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes

NCT02319941

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients with Acute Coronary Syndromes

Timeline

Start
2015-05-20
Primary completion
2017-02-14
Completion
2017-03-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg
Subject Ticagrelor Small molecule 60 mg
Subject Ticagrelor Small molecule 90 mg